AARTI DRUGS
|
AARTI DRUGS Last 5 Year Balance Sheet History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
EQUITY AND LIABILITIES | |||||
Share Capital | ₹92 Cr | ₹93 Cr | ₹93 Cr | ₹93 Cr | ₹23 Cr |
Equity - Authorised | ₹120 Cr | ₹120 Cr | ₹120 Cr | ₹120 Cr | ₹25 Cr |
Equity - Issued | ₹92 Cr | ₹93 Cr | ₹93 Cr | ₹93 Cr | ₹23 Cr |
Equity Paid Up | ₹92 Cr | ₹93 Cr | ₹93 Cr | ₹93 Cr | ₹23 Cr |
Equity Shares Forfeited | - | - | - | - | - |
Adjustments to Equity | - | - | - | - | - |
Preference Capital Paid Up | - | - | - | - | - |
Face Value | ₹10.00 | ₹10.00 | ₹10.00 | ₹10.00 | ₹10.00 |
Share Warrants & Outstandings | - | - | - | - | - |
Total Reserves | ₹1,190 Cr | ₹1,100 Cr | ₹944 Cr | ₹820 Cr | ₹629 Cr |
Securities Premium | - | - | - | - | - |
Capital Reserves | ₹6.28 Cr | ₹6.28 Cr | ₹6.28 Cr | ₹6.28 Cr | ₹6.28 Cr |
Profit & Loss Account Balance | ₹1,155 Cr | ₹1,021 Cr | ₹879 Cr | ₹754 Cr | ₹592 Cr |
General Reserves | ₹15 Cr | ₹61 Cr | ₹45 Cr | ₹48 Cr | ₹22 Cr |
Other Reserves | ₹13 Cr | ₹12 Cr | ₹13 Cr | ₹12 Cr | ₹8.76 Cr |
Reserve excluding Revaluation Reserve | ₹1,190 Cr | ₹1,100 Cr | ₹944 Cr | ₹820 Cr | ₹629 Cr |
Revaluation reserve | - | - | - | - | - |
Shareholder's Funds | ₹1,282 Cr | ₹1,192 Cr | ₹1,036 Cr | ₹913 Cr | ₹652 Cr |
Minority Interest | ₹0.41 Cr | ₹0.23 Cr | ₹-0.06 Cr | ₹-0.02 Cr | ₹0.00 Cr |
Long-Term Borrowings | - | - | - | - | - |
Secured Loans | ₹272 Cr | ₹196 Cr | ₹130 Cr | ₹139 Cr | ₹172 Cr |
Non Convertible Debentures | - | - | - | - | - |
Converible Debentures & Bonds | - | - | - | - | - |
Packing Credit - Bank | - | - | - | - | - |
Inter Corporate & Security Deposit | - | - | - | - | - |
Term Loans - Banks | ₹544 Cr | ₹392 Cr | ₹173 Cr | ₹139 Cr | ₹213 Cr |
Term Loans - Institutions | - | - | - | - | - |
Other Secured | ₹-272 Cr | ₹-196 Cr | ₹-44 Cr | - | ₹-41 Cr |
Unsecured Loans | ₹3.57 Cr | ₹8.57 Cr | ₹8.57 Cr | ₹8.57 Cr | ₹8.57 Cr |
Fixed Deposits - Public | - | - | - | - | - |
Loans and advances from subsidiaries | - | - | - | - | - |
Inter Corporate Deposits (Unsecured) | - | - | - | - | - |
Foreign Currency Convertible Notes | - | - | - | - | - |
Long Term Loan in Foreign Currency | - | - | - | - | - |
Loans - Banks | - | - | - | - | - |
Loans - Govt. | - | - | - | - | - |
Loans - Others | ₹3.57 Cr | ₹8.57 Cr | ₹8.57 Cr | ₹8.57 Cr | ₹8.57 Cr |
Other Unsecured Loan | - | - | - | - | - |
Deferred Tax Assets / Liabilities | ₹76 Cr | ₹71 Cr | ₹72 Cr | ₹77 Cr | ₹81 Cr |
Deferred Tax Assets | - | - | - | - | - |
Deferred Tax Liability | ₹76 Cr | ₹71 Cr | ₹72 Cr | ₹77 Cr | ₹81 Cr |
Other Long Term Liabilities | ₹1.08 Cr | ₹0.57 Cr | ₹2.05 Cr | ₹4.55 Cr | ₹7.79 Cr |
Long Term Trade Payables | - | - | ₹9.39 Cr | ₹6.34 Cr | ₹6.87 Cr |
Long Term Provisions | ₹2.74 Cr | ₹3.04 Cr | ₹9.23 Cr | ₹22 Cr | ₹25 Cr |
Total Non-Current Liabilities | ₹355 Cr | ₹279 Cr | ₹232 Cr | ₹257 Cr | ₹301 Cr |
Current Liabilities | - | - | - | - | - |
Trade Payables | ₹425 Cr | ₹480 Cr | ₹469 Cr | ₹330 Cr | ₹330 Cr |
Sundry Creditors | ₹425 Cr | ₹480 Cr | ₹469 Cr | ₹330 Cr | ₹330 Cr |
Acceptances | - | - | - | - | - |
Due to Subsidiaries- Trade Payables | - | - | - | - | - |
Other Current Liabilities | ₹151 Cr | ₹100 Cr | ₹111 Cr | ₹105 Cr | ₹133 Cr |
Bank Overdraft / Short term credit | - | - | - | - | - |
Advances received from customers | ₹21 Cr | ₹11 Cr | - | - | - |
Interest Accrued But Not Due | ₹2.21 Cr | ₹1.71 Cr | ₹1.02 Cr | ₹0.80 Cr | ₹0.71 Cr |
Share Application Money | - | - | - | - | - |
Current maturity of Debentures & Bonds | - | - | - | - | - |
Current maturity - Others | - | - | - | - | - |
Other Liabilities | ₹128 Cr | ₹87 Cr | ₹110 Cr | ₹105 Cr | ₹132 Cr |
Short Term Borrowings | ₹215 Cr | ₹361 Cr | ₹356 Cr | ₹157 Cr | ₹158 Cr |
Secured ST Loans repayable on Demands | ₹172 Cr | ₹311 Cr | ₹343 Cr | ₹96 Cr | ₹86 Cr |
Working Capital Loans- Sec | ₹172 Cr | ₹311 Cr | ₹343 Cr | ₹96 Cr | ₹86 Cr |
Buyers Credits - Unsec | - | - | - | - | - |
Commercial Borrowings- Unsec | - | - | - | - | - |
Other Unsecured Loans | ₹-130 Cr | ₹-262 Cr | ₹-329 Cr | ₹-34 Cr | ₹-14 Cr |
Short Term Provisions | ₹4.14 Cr | ₹8.60 Cr | ₹3.71 Cr | ₹2.80 Cr | ₹3.08 Cr |
Proposed Equity Dividend | - | - | - | - | - |
Provision for Corporate Dividend Tax | - | - | - | - | - |
Provision for Tax | ₹1.18 Cr | ₹4.23 Cr | - | - | - |
Provision for post retirement benefits | - | - | - | ₹2.80 Cr | - |
Preference Dividend | - | - | - | - | - |
Other Provisions | ₹2.95 Cr | ₹4.37 Cr | ₹3.71 Cr | - | ₹3.08 Cr |
Total Current Liabilities | ₹796 Cr | ₹949 Cr | ₹940 Cr | ₹595 Cr | ₹623 Cr |
Total Liabilities | ₹2,432 Cr | ₹2,421 Cr | ₹2,208 Cr | ₹1,766 Cr | ₹1,577 Cr |
ASSETS | |||||
Gross Block | ₹1,388 Cr | ₹1,202 Cr | ₹1,169 Cr | ₹1,101 Cr | ₹1,031 Cr |
Less: Accumulated Depreciation | ₹577 Cr | ₹526 Cr | ₹479 Cr | ₹436 Cr | ₹387 Cr |
Less: Impairment of Assets | - | - | - | - | - |
Net Block | ₹811 Cr | ₹676 Cr | ₹690 Cr | ₹665 Cr | ₹644 Cr |
Lease Adjustment A/c | - | - | - | - | - |
Capital Work in Progress | ₹225 Cr | ₹187 Cr | ₹77 Cr | ₹19 Cr | ₹12 Cr |
Non Current Investments | ₹20 Cr | ₹19 Cr | ₹19 Cr | ₹17 Cr | ₹13 Cr |
Long Term Investment | ₹20 Cr | ₹19 Cr | ₹19 Cr | ₹17 Cr | ₹13 Cr |
Quoted | - | - | - | - | - |
Unquoted | ₹20 Cr | ₹19 Cr | ₹19 Cr | ₹17 Cr | ₹13 Cr |
Long Term Loans & Advances | ₹20 Cr | ₹24 Cr | ₹28 Cr | ₹7.26 Cr | ₹3.12 Cr |
Other Non Current Assets | - | - | - | - | - |
Total Non-Current Assets | ₹1,112 Cr | ₹930 Cr | ₹815 Cr | ₹709 Cr | ₹673 Cr |
Current Assets Loans & Advances | - | - | - | - | - |
Currents Investments | - | - | - | - | - |
Quoted | - | - | - | - | - |
Unquoted | - | - | - | - | - |
Inventories | ₹486 Cr | ₹516 Cr | ₹526 Cr | ₹415 Cr | ₹325 Cr |
Raw Materials | ₹183 Cr | ₹197 Cr | ₹222 Cr | ₹199 Cr | ₹122 Cr |
Work-in Progress | ₹128 Cr | ₹173 Cr | ₹163 Cr | ₹112 Cr | ₹101 Cr |
Finished Goods | ₹136 Cr | ₹117 Cr | ₹125 Cr | ₹89 Cr | ₹89 Cr |
Packing Materials | ₹5.19 Cr | ₹4.78 Cr | ₹5.62 Cr | ₹3.71 Cr | ₹3.56 Cr |
Stores  and Spare | ₹20 Cr | ₹15 Cr | ₹11 Cr | ₹10 Cr | ₹9.44 Cr |
Other Inventory | ₹13 Cr | ₹9.60 Cr | ₹0.08 Cr | - | - |
Sundry Debtors | ₹705 Cr | ₹865 Cr | ₹750 Cr | ₹555 Cr | ₹489 Cr |
Debtors more than Six months | ₹43 Cr | ₹35 Cr | ₹27 Cr | ₹20 Cr | ₹2.88 Cr |
Debtors Others | ₹664 Cr | ₹834 Cr | ₹727 Cr | ₹539 Cr | ₹487 Cr |
Cash and Bank | ₹9.43 Cr | ₹8.96 Cr | ₹22 Cr | ₹9.78 Cr | ₹7.64 Cr |
Cash in hand | ₹0.26 Cr | ₹0.28 Cr | ₹0.24 Cr | ₹0.30 Cr | ₹0.29 Cr |
Balances at Bank | ₹7.12 Cr | ₹7.80 Cr | ₹22 Cr | ₹7.93 Cr | ₹7.12 Cr |
Other cash and bank balances | ₹2.05 Cr | ₹0.88 Cr | ₹0.53 Cr | ₹1.55 Cr | ₹0.24 Cr |
Other Current Assets | ₹3.23 Cr | ₹3.04 Cr | ₹0.70 Cr | ₹2.44 Cr | ₹2.27 Cr |
Interest accrued on Investments | - | - | - | - | - |
Interest accrued on Debentures | - | - | - | - | - |
Deposits with Government | - | - | - | - | - |
Interest accrued and or due on loans | - | - | - | - | - |
Prepaid Expenses | ₹2.78 Cr | ₹2.35 Cr | - | - | - |
Other current_assets | ₹0.45 Cr | ₹0.70 Cr | ₹0.70 Cr | ₹2.44 Cr | ₹2.27 Cr |
Short Term Loans and Advances | ₹118 Cr | ₹99 Cr | ₹95 Cr | ₹74 Cr | ₹76 Cr |
Advances recoverable in cash or in kind | ₹14 Cr | ₹14 Cr | ₹23 Cr | ₹20 Cr | ₹38 Cr |
Advance income tax and TDS | - | - | - | - | - |
Amounts due from directors | - | - | - | - | - |
Due From Subsidiaries | - | - | - | - | - |
Inter corporate deposits | - | - | - | - | - |
Corporate Deposits | - | - | - | - | - |
Other Loans & Advances | ₹104 Cr | ₹85 Cr | ₹71 Cr | ₹54 Cr | ₹37 Cr |
Total Current Assets | ₹1,321 Cr | ₹1,492 Cr | ₹1,393 Cr | ₹1,057 Cr | ₹899 Cr |
Net Current Assets (Including Current Investments) | ₹525 Cr | ₹542 Cr | ₹453 Cr | ₹461 Cr | ₹276 Cr |
Miscellaneous Expenses not written off | - | - | - | - | - |
Total Assets | ₹2,432 Cr | ₹2,421 Cr | ₹2,208 Cr | ₹1,766 Cr | ₹1,577 Cr |
Contingent Liabilities | ₹249 Cr | ₹194 Cr | ₹185 Cr | ₹151 Cr | ₹88 Cr |
Total Debt | ₹562 Cr | ₹607 Cr | ₹538 Cr | ₹344 Cr | ₹379 Cr |
Book Value | - | 128.77 | 111.92 | 98.01 | 280.04 |
Adjusted Book Value | 139.40 | 128.77 | 111.92 | 98.01 | 70.01 |
Compare Balance Sheet of peers of AARTI DRUGS
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
AARTI DRUGS | ₹4,129.5 Cr | 8.8% | 3.8% | -14.5% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹441,838.0 Cr | 1% | 0.7% | 47.3% | Stock Analytics | |
DIVIS LABORATORIES | ₹156,107.0 Cr | -1.1% | -5.8% | 61.7% | Stock Analytics | |
CIPLA | ₹120,270.0 Cr | 0.3% | -1.8% | 19.6% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹113,077.0 Cr | 6% | 11.8% | 20.3% | Stock Analytics | |
ZYDUS LIFESCIENCES | ₹96,553.2 Cr | -1.5% | -0.1% | 47% | Stock Analytics |
AARTI DRUGS Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
AARTI DRUGS | 8.8% |
3.8% |
-14.5% |
SENSEX | -2.1% |
-2% |
11.3% |
You may also like the below Video Courses